Breast Cancer Screening Articles & Analysis
23 news found
Milan, Italy, September 3, 2024 — Tethis S.p.A., a pioneer in the development of a standardized liquid biopsy platform, announces a collaboration with Weill Cornell Medicine to test Tethis’ instruments for monitoring the response to curative treatment in patients with early-stage breast cancer. The scientists will collect blood from the patients and will measure the number and kind ...
Tempus, a leader in artificial intelligence and precision medicine, today announced the clinical launch of its minimal residual disease (MRD) test portfolio, including Tempus’ xM test and the xM (NeXT Personal® Dx) test by Personalis. The portfolio features both a tumor-naïve assay and a tumor-informed assay that are designed to help detect residual disease or early cancer ...
ByTempus
InHealth, who provide services for North and East Devon NHS Breast Screening, has entered into the research agreement to work with Kheiron Medical Technologies as part of the AI in Health & Care Award. This partnership marks another significant step in the journey to build an evidence base to demonstrate the effectiveness and safety of artificial intelligence ...
“Our diagnostics pipeline currently includes SubB2M-based tests in development for monitoring breast and ovarian cancers and an exosome-based ovarian cancer screening ...
Women are increasingly aware of the cancer risk associated with breast density. QVCAD Invenia ABUS combination provides a solution that has the potential to be the preferred screening method for women with dense breast parenchyma. ...
The Transpara AI breast care solution, now being used in over 30 countries worldwide to find breast cancers faster and earlier, has 'remarkable potential' to reduce Radiologists' workload, according to a leading research team in Spain. ...
Elizabeth Morris, and Dr. Amy Patel to its US Breast Medical Advisory Board. These appointments reinforce Kheiron’s focus on bringing its artificial intelligence solutions to the US market to help radiologists detect breast cancer earlier. Kheiron is committed to assembling an inclusive advisory board that shares its mission for creating ...
The team running the country's largest breast screening programme have shown that using Transpara breast AI further confirmed the enormous contribution of this technology to breast cancer detection: not only to reduce the number of false positives but also to reduce radiologists' workload by over 60%. ...
While Artificial intelligence (AI) has shown promising results for cancer detection in mammographic screening, solid evidence based on complete follow up of participants and accurate characterization of cancers remains sparse. ...
He has been instrumental in launching and scaling many industry-first technologies including the first Computer Aided Detection algorithm for the early detection of breast cancer, the first mammography analytics platform and a multi-point risk stratified breast screening scorecard. ...
It is known that overall, up to 25% of breast cancers are missed by screening and considered detectable in retrospect. ...
The manuscript, published in Lymphatic Research and Biology, concluded “[L-Dex] screening should be a standard approach for prospective breast cancer-related lymphedema surveillance” and is available online here: https://www.liebertpub.com/doi/10.1089/lrb.2021.0084. ...
Invenia ABUS 2.0 is the first FDA-approved Ultrasound supplemental breast screening technology specifically designed for detecting cancer in dense breast tissue. ...
” ScreenPoint’s AI algorithm, Transpara, assists breast radiologists in improving their accuracy for both 2D and 3D mammography, which can help detect cancers earlier and reduce overall reading time. ...
ByAidoc
“The Polish healthcare system is known for providing advanced cancer treatment and adopting new therapies and technologies. As breast cancer continues to be one of the most common types of cancer among Polish women, with a reported 24,644 women diagnosed in 20201, Poland has joined the global effort to increase ...
The parties at the signing ceremony have agreed to co-develop Breast Cancer Centers of Excellence which will deliver comprehensive, compassionate breast cancer care combined with advanced basic and translational cancer research. ...
(DHI Pacific) and Aurora Healthcare US Corp (Aurora) are pleased to announce the signing of a landmark collaboration memorandum that leverages the shared interests and diverse expertise of the two companies to develop comprehensive breast cancer centers of excellence in China. Breast cancer surpassed lung cancer ...
Led by Winnie chiu-wing Chu MD, Professor of radiology at CUHK and Abraham Morse MD, Medical Director of Aurora, the joint project will investigate the potential advantages and challenges of using breast-dedicated MRI for first-line breast cancer screening in Chinese women with dense breasts, for whom the ...
With the COVID-19 pandemic pushing breast cancer screening to the back burner for many patients, scanner and software manufacturers have more reason than ever to bring products to the market that make scans faster and more comfortable, and helping radiologists manage their growing worklists. ...
With the help of LU DF LAB, VITA female oncology patient association, Semper Anticus we are launching Skrinings.lv in Latvia - a digital platform for breast cancer pre-screening, associated risk calculation, and community proactive involvement in research initiatives. Skrinigs.lv is a web platform, available in 3 languages (Latvian, English, ...